Quest Diagnostics 2011 Annual Report Download - page 25

Download and view the complete annual report

Please find page 25 of the 2011 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Our internet site is www.QuestDiagnostics.com. You can access Quest Diagnostics’ Investor Relations
webpage at www.QuestDiagnostics.com/investor. The information on our website is not incorporated by reference
into this Report. We make available free of charge, on or through our Investor Relations webpage, our proxy
statements, Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), as soon as reasonably practical after such material is filed with, or furnished to, the SEC.
We also make available, through our Investor Relations webpage, statements of beneficial ownership of our
equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the
Exchange Act.
We have a corporate governance webpage. You can access information regarding our corporate governance
at www.QuestDiagnostics.com/governance. We post the following on our corporate governance webpage:
•Directors
•Management
•Code of Business Ethics
•Integrity Commitment
•Values
•Corporate Governance Guidelines
•Charters for the following committees of our Board of Directors: Audit and Finance; Compensation;
Executive; Governance; and Quality, Safety and Compliance
•Certificate of Incorporation
•Bylaws
EXECUTIVE OFFICERS OF THE COMPANY
The following persons serve as executive officers of the Company.
Surya N. Mohapatra, Ph.D. (62) is Chairman of the Board, President and Chief Executive Officer. Prior to
joining the Company in February 1999 as Senior Vice President and Chief Operating Officer, he was Senior Vice
President of Picker International, a worldwide leader in advanced medical imaging technologies. Dr. Mohapatra
was appointed President and Chief Operating Officer in June 1999, Chief Executive Officer in May 2004 and
Chairman of the Board in December 2004. He is a director of Xylem Inc., a trustee of The Rockefeller
University and a member of the Corporate Advisory Board of Johns Hopkins Carey Business School. Dr.
Mohapatra was a director of ITT Corporation from 2008 to October 2011. He has been a director of the
Company since 2002.
Jon R. Cohen, M.D. (57) is Senior Vice President, Hospital Services and Chief Medical Officer. Dr. Cohen
joined the company in March 2009 and served as Chief Medical Officer until May 2011, when he also assumed
responsibility for Hospital Services. He served as the Senior Advisor to New York Governor David Patterson
from 2008 to 2009, where he was responsible for all policy and strategic planning. From 2007 to 2008, Dr.
Cohen was a managing director, health industries advisory services at PricewaterhouseCoopers LLP. Prior to that,
he spent 21 years with North Shore-Long Island Jewish Health System, one of the nation’s largest not-for-profit
health systems, including serving as its Chief Medical Officer from 2000 to 2006.
Catherine T. Doherty (49) is Senior Vice President, Physician Services Business. She joined the Company in
1990 and from 2008 through May 2011 served as the Vice President, Hospital Services. Prior to 2008, Ms.
Doherty held a variety of positions of increasing responsibility, including Vice President, Office of the Chairman;
Vice President, Finance and Administration for the Hospital business; Vice President, Investor Relations; and
Chief Accounting Officer.
Robert A. Hagemann (55) is Senior Vice President and Chief Financial Officer. He joined Corning Life
Sciences, Inc. in 1992, where he held a variety of senior financial positions before being named Vice President
and Corporate Controller of the Company in 1996. Mr. Hagemann has served as Chief Financial Officer since
August 1998. He is a director of Zimmer Holdings, Inc.
Joan E. Miller, Ph.D. (57) is Senior Vice President, Pathology and Neurology. Dr. Miller joined Corning
Life Sciences, Inc. in 1992 and since has held positions of increasing responsibility. Dr. Miller was named Senior
Managing Director, Nichols Institute in 2002 and Vice President, Hospital Business in 2003. From June 2007
until May 2011, Dr. Miller had responsibility for the Company’s Hospital Services, including its esoteric testing
19